Sherry Rohekar

7PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsVeterinary epidemiologyToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 31, 2025
Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian study.

Raphaël Hurtubise, Sherry Rohekar, Nigil Haroon

|Jul 01, 2024
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis.

Sherry Rohekar, Jordi Pardo Pardo, Reza Mirza

|May 05, 2024
Real-World Treatment Patterns, Clinical Outcomes, and Symptom Burden in Patients With Psoriatic Arthritis Prescribed Ixekizumab in the United States.

Sherry Rohekar, Aisha Vadhariya, Sarah Ross

|Feb 15, 2024
Residual Disease Activity in Canadian Patients With Psoriatic Arthritis Treated With Advanced Therapies: Results From a Multiregistry Analysis (UNISON-PsA).

Dafna D Gladman, Vinod Chandran, Cheryl F Rosen

|Dec 01, 2022
Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial Spondyloarthritis.

Robert D Inman, Marco Garrido-Cumbrera, Jonathan Chan

|Oct 15, 2022
Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.

Ying-Ying Leung, Tatiana V Korotaeva, Liliana Candia

Pageof 2

Frequent Collaborators

4 joint publications

Nigil Haroon

4 joint publications

Robert Inman

3 joint publications

Nicolas Richard

3 joint publications

Lihi Eder